Three patients with hepatocellular carcinoma (HCC) and inferior vena cava tumor thrombus (IVCTT) were treated using proton beam therapy at the University of Tsukuba, Japan. A total dose of 50–70 Gy in 10–35 fractions was given to the primary tumor and IVCTT. All the patients survived for more than 1 year from the beginning of proton beam therapy (13–55 months) and no treatment-related toxicity of grade 3 or higher was observed. These cases suggest that proton beam therapy is safe and effective for patients with HCC associated with IVCTT. Key words: hepatocellular carcinoma – inferior vena cava tumor thrombus – proton beam therapy – radiation – hepatom
Introduction: Proton beam therapy (PBT) is known to be an effective locoregional treatment for hepat...
Introduction: Proton beam therapy (PBT) is known to be an effective locoregional treatment for hepat...
We evaluated the effectiveness and toxicity of proton beam therapy (PBT) for hepatocellular carcinom...
Three patients with hepatocellular carcinoma (HCC) and inferior vena cava tumor thrombus (IVCTT) wer...
BACKGROUND:: The authors have published a series of studies evaluating the safety and efficacy of pr...
Background and Purpose: The prognosis of patients with advanced hepatocellular carcinoma (HCC) with ...
PURPOSE: To investigate the safety and efficacy of proton beam therapy (PBT) in patients with large ...
Proton radiation therapy plays a central role in the treatment of hepatocellular carcinoma (HCC). Be...
Hepatocellular carcinoma (HCC) is the most common primary liver cancer, the sixth most common cancer...
[[abstract]]BACKGROUND: Hepatocellular carcinoma (HCC) with inferior vena cava (IVC) involvement is ...
The purpose of this study is to determine the optimal dose of proton beam therapy (PBT) in hepatocel...
Background: Hepatocellular carcinoma with inferior vena cava invasion is a rare but fatal condition ...
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death, and external beam radiati...
Surgical resection is the first choice for treatment of a thymic carcinoid tumor and radiotherapy is...
The purpose of this study is to determine the optimal dose of proton beam therapy (PBT) in hepatocel...
Introduction: Proton beam therapy (PBT) is known to be an effective locoregional treatment for hepat...
Introduction: Proton beam therapy (PBT) is known to be an effective locoregional treatment for hepat...
We evaluated the effectiveness and toxicity of proton beam therapy (PBT) for hepatocellular carcinom...
Three patients with hepatocellular carcinoma (HCC) and inferior vena cava tumor thrombus (IVCTT) wer...
BACKGROUND:: The authors have published a series of studies evaluating the safety and efficacy of pr...
Background and Purpose: The prognosis of patients with advanced hepatocellular carcinoma (HCC) with ...
PURPOSE: To investigate the safety and efficacy of proton beam therapy (PBT) in patients with large ...
Proton radiation therapy plays a central role in the treatment of hepatocellular carcinoma (HCC). Be...
Hepatocellular carcinoma (HCC) is the most common primary liver cancer, the sixth most common cancer...
[[abstract]]BACKGROUND: Hepatocellular carcinoma (HCC) with inferior vena cava (IVC) involvement is ...
The purpose of this study is to determine the optimal dose of proton beam therapy (PBT) in hepatocel...
Background: Hepatocellular carcinoma with inferior vena cava invasion is a rare but fatal condition ...
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death, and external beam radiati...
Surgical resection is the first choice for treatment of a thymic carcinoid tumor and radiotherapy is...
The purpose of this study is to determine the optimal dose of proton beam therapy (PBT) in hepatocel...
Introduction: Proton beam therapy (PBT) is known to be an effective locoregional treatment for hepat...
Introduction: Proton beam therapy (PBT) is known to be an effective locoregional treatment for hepat...
We evaluated the effectiveness and toxicity of proton beam therapy (PBT) for hepatocellular carcinom...